Showing results (1-10 of 49) with videos related to
Sort By:
Pageof 5
Cell Chemical Biology|February 19, 2017
The Holy Grail: Solid Tumor Efficacy by Proteasome InhibitionMark RolfeClinical Journal of the American Society of Nephrology : CJASN|February 13, 2010
Potassium homeostasis and renin-angiotensin-aldosterone system inhibitorsMatthew R Weir, Mark RolfeThe Biochemical Journal|May 2, 2003
Ca(2+)-independent protein kinase C activity is required for alpha1-adrenergic-receptor-mediated regulation of ribosomal protein S6 kinases in adult cardiomyocytesLijun Wang, Mark Rolfe, Christopher G ProudNature Reviews. Drug Discovery|July 4, 2006
Drug discovery in the ubiquitin-proteasome systemGrzegorz Nalepa, Mark Rolfe, J Wade HarperEuropean Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|February 27, 2019
Attributes of analgesics for emergency pain relief: results of the Consensus on Management of Pain Caused by Trauma Delphi initiativeKeith Porter, Bart Morlion, Mark Rolfe, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 11, 2009
Targeting NEDD8-activated cullin-RING ligases for the treatment of cancerTeresa A Soucy, Peter G Smith, Mark RolfeGenome Biology|May 8, 2003
Duplication and selection in the evolution of primate beta-defensin genesColin A M Semple, Mark Rolfe, Julia R DorinThe Biochemical Journal|March 11, 2005
Activation of protein synthesis in cardiomyocytes by the hypertrophic agent phenylephrine requires the activation of ERK and involves phosphorylation of tuberous sclerosis complex 2 (TSC2)Mark Rolfe, Laura E McLeod, Phillip F Pratt, et al.Asian Cardiovascular & Thoracic Annals|February 27, 2014
Reconstruction of pulmonary venous conduit with CorMatrix in lung transplantWing C Yeen, Cristiano Faber, Christiano Caldeira, et al.American Journal of Clinical Pathology|April 25, 2003
Anticancer antibodiesJeffrey S Ross, Karen Gray, Gary S Gray, et al.Pageof 5